Literature DB >> 33031756

Mechanical Feed-Forward Loops Contribute to Idiopathic Pulmonary Fibrosis.

Margaret A T Freeberg1, Apostolos Perelas1, Jane K Rebman1, Richard P Phipps2, Thomas H Thatcher1, Patricia J Sime3.   

Abstract

Idiopathic pulmonary fibrosis is a progressive scarring disease characterized by extracellular matrix accumulation and altered mechanical properties of lung tissue. Recent studies support the hypothesis that these compositional and mechanical changes create a progressive feed-forward loop in which enhanced matrix deposition and tissue stiffening contribute to fibroblast and myofibroblast differentiation and activation, which further perpetuates matrix production and stiffening. The biomechanical properties of tissues are sensed and responded to by mechanotransduction pathways that facilitate sensing of changes in mechanical cues by tissue resident cells and convert the mechanical signals into downstream biochemical signals. Although our understanding of mechanotransduction pathways associated with pulmonary fibrosis remains incomplete, recent progress has allowed us to begin to elucidate the specific mechanisms supporting fibrotic feed-forward loops. The mechanosensors discussed here include integrins, Piezo channels, transient receptor potential channels, and nonselective ion channels. Also discussed are downstream transcription factors, including myocardin-related transcription factor and Yes-associated protein/transcriptional coactivator with PDZ-binding motif. This review describes mechanosensors and mechanotransduction pathways associated with fibrosis progression and highlights promising therapeutic insights.
Copyright © 2021 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33031756      PMCID: PMC7768346          DOI: 10.1016/j.ajpath.2020.09.008

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  7 in total

Review 1.  Cell-3D matrix interactions: recent advances and opportunities.

Authors:  Kenneth M Yamada; Andrew D Doyle; Jiaoyang Lu
Journal:  Trends Cell Biol       Date:  2022-04-08       Impact factor: 21.167

Review 2.  From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?

Authors:  Jacob E Michalski; Jonathan S Kurche; David A Schwartz
Journal:  Transl Res       Date:  2021-09-20       Impact factor: 10.171

3.  Resident Fibroblast MKL1 Is Sufficient to Drive Pro-fibrogenic Response in Mice.

Authors:  Shan Huang; Tinghui Shao; Hong Liu; Tianfa Li; Xianhua Gui; Qianwen Zhao
Journal:  Front Cell Dev Biol       Date:  2022-02-01

4.  Mechanism of Fei-Xian Formula in the Treatment of Pulmonary Fibrosis on the Basis of Network Pharmacology Analysis Combined with Molecular Docking Validation.

Authors:  Xiao-Li Chen; Cheng Tang; Qing-Ling Xiao; Zhong-Hua Pang; Dan-Dan Zhou; Jin Xu; Qi Wang; Ya-Xi Zhao; Qi-Yong Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-03       Impact factor: 2.629

5.  A scalable 3D tissue culture pipeline to enable functional therapeutic screening for pulmonary fibrosis.

Authors:  Katherine A Cummins; Peter B Bitterman; Daniel J Tschumperlin; David K Wood
Journal:  APL Bioeng       Date:  2021-11-16

Review 6.  Piezo1 Channel as a Potential Target for Hindering Cardiac Fibrotic Remodeling.

Authors:  Nicoletta Braidotti; Suet Nee Chen; Carlin S Long; Dan Cojoc; Orfeo Sbaizero
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

Review 7.  The Genomic Response to TGF-β1 Dictates Failed Repair and Progression of Fibrotic Disease in the Obstructed Kidney.

Authors:  Craig E Higgins; Jiaqi Tang; Stephen P Higgins; Cody C Gifford; Badar M Mian; David M Jones; Wenzheng Zhang; Angelica Costello; David J Conti; Rohan Samarakoon; Paul J Higgins
Journal:  Front Cell Dev Biol       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.